GEXVal Invited to Speak at Certainty Japan 2026
2026/6/18
GEXVal Inc.June 18, 2026 GEXVal Head of R&D CMC Selected as Invited Speaker at Certainty Japan 2026 GEXV […]
GEXVal Receives EMA’s CHMP Scientific Advice for Lead Pipeline GXV-001
2026/5/21
GEXVal Inc.May 21, 2026 GEXVal Receives Scientific Advice from EMA’s CHMP for Lead Pipeline GXV-001 in Fragile […]
GEXVal Selected as Presenting Company at BioEquity Europe 2026
2026/5/7
GEXVal Inc.May 7, 2026 GEXVal CEO Selected to Present at BioEquity Europe 2026 GEXVal Inc. (President & […]
GEXVal CEO Selected as Invited Speaker at CPHI Japan 2026
2026/4/15
GEXVal Inc.April 15, 2026 GEXVal CEO Selected as Invited Speaker at Drug Discovery Symposium of CPHI Japan 202 […]

